Advanced search
Publication Cover
mAbs Volume 14, 2022 - Issue 1
Submit an article Journal homepage
4,962
Views
12
CrossRef citations to date
0
Altmetric
Report

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system

Sofia S. Guimaraes Kocha INN Unit, WHO, Geneva, SwitzerlandCorrespondence[email protected]
View further author information
,
Robin Thorpeb Welwyn, UKView further author information
,
Nana Kawasakic Yokohama City University, Yokohama, JapanORCID Iconhttps://orcid.org/0000-0002-5447-1890View further author information
ORCID Icon,
Marie-Paule Lefrancd Institut Universitaire de France, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, Montpellier, FranceView further author information
,
Sarel Malane School of Pharmacy, University of the Western Cape, Bellville, South AfricaORCID Iconhttps://orcid.org/0000-0002-1640-6457View further author information
ORCID Icon,
Andrew C.R. Martinf Institute of Structural & Molecular Biology, Division of Biosciences, University College London, London, UKView further author information
,
Gilles Mignotg Nice, FranceView further author information
,
Andreas Plückthunh Department of Biochemistry, University of Zurich, Zurich, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-4191-5306View further author information
ORCID Icon,
Menico Rizzii Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, ItalyView further author information
,
Stephanie Shubatj United States Adopted Names (USAN) Program, Chicago, Illinois, USAView further author information
,
Karin Weisserk Paul-Ehrlich-Institut, Langen, GermanyView further author information
&
Raffaella Baloccoa INN Unit, WHO, Geneva, SwitzerlandView further author information
 show all
Article: 2075078 | Received 22 Feb 2022, Accepted 04 May 2022, Published online: 18 May 2022

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ana Antunes, Luis Alvarez-Vallina, Federico Bertoglio, Nicolas Bouquin, Stéphanie Cornen, Francis Duffieux, Pierre Ferré, Raphaëlle Gillet, Christian Jorgensen, Mark B Leick, Bernard Maillère, Hélène Negre, Mireia Pelegrin, Nicolas Poirier, Dietmar Reusch, Bruno Robert, Guy Serre, Alain Vicari, Martin Villalba, Christoph Volpers, Gavin Vuddamalay, Hervé Watier, Thierry Wurch, Lennart Zabeau, Stefan Zielonka, Baolin Zhang, Alain Beck & Pierre Martineau. (2023) 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. mAbs 15:1.
Read now
Kyle P. Martin, Christine Grimaldi, Rolf Grempler, Steven Hansel & Sandeep Kumar. (2023) Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics. mAbs 15:1.
Read now
Ian Wilkinson & Geoff Hale. (2022) Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. mAbs 14:1.
Read now

Articles from other publishers (9)

Naomi Karmi, Werna T.C. Uniken Venema, Frans van der Heide, Eleonora A.M. Festen & Gerard Dijkstra. (2024) Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art. Human Immunology 85:4, pages 110810.
Crossref
William R Strohl. (2024) Structure and function of therapeutic antibodies approved by the US FDA in 2023. Antibody Therapeutics 7:2, pages 132-156.
Crossref
Nikolas Tauber, Christoph Cirkel, Anna Claussen, Franziska Fick, Emmanuel Kontomanolis, Natalia Krawczyk, Achim Rody & Maggie Banys-Paluchowski. (2024) HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?. Cancers 16:6, pages 1121.
Crossref
Mostafa Meshaal Ahmad. (2024) Clinical pharmacology of biological medicines. Medicine 52:1, pages 51-55.
Crossref
Mirosława Püsküllüoğlu, Agnieszka Rudzińska & Renata Pacholczak-Madej. (2023) Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188991.
Crossref
Taciana Manso, Anjana Kushwaha, Nika Abdollahi, Patrice Duroux, Véronique Giudicelli & Sofia Kossida. (2023) Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB. Frontiers in Immunology 14.
Crossref
Mark P. Lythgoe. (2022) No new ‘mabs’ in medicine—New nomenclature for monoclonal antibodies. British Journal of Pharmacology 179:24, pages 5338-5339.
Crossref
Marie-Paule Lefranc & Gérard Lefranc. (2022) IMGT® Nomenclature of Engineered IGHG Variants Involved in Antibody Effector Properties and Formats. Antibodies 11:4, pages 65.
Crossref
Alexander C. Martins, Mariana Y. Oshiro, Fernando Albericio, Beatriz G. de la Torre, Gustavo José V. Pereira & Rodrigo V. Gonzaga. (2022) Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. Biomedicines 10:9, pages 2325.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.